|
1
|
Hart LG, Deyo RA and Cherkin DC: Physician
office visits for low back pain. Frequency, clinical evaluation,
and treatment patterns from a U.S. national survey. Spine (Phila Pa
1976). 20:11–19. 1995.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Katz JN: Lumbar disc disorders and
low-back pain: Socioeconomic factors and consequences. J Bone Joint
Surg Am. 88: (Suppl 2):S21–S24. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Vo NV, Hartman RA, Yurube T, Jacobs LJ,
Sowa GA and Kang JD: Expression and regulation of
metalloproteinases and their inhibitors in intervertebral disc
aging and degeneration. Spine J. 13:331–341. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kepler CK, Ponnappan RK, Tannoury CA,
Risbud MV and Anderson DG: The molecular basis of intervertebral
disc degeneration. Spine J. 13:318–330. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lee S, Moon CS, Sul D, Lee J, Bae M, Hong
Y, Lee M, Choi S, Derby R, Kim BJ, et al: Comparison of growth
factor and cytokine expression in patients with degenerated disc
disease and herniated nucleus pulposus. Clin Biochem. 42:1504–1511.
2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kim JS, Ellman MB, Yan D, An HS, Kc R, Li
X, Chen D, Xiao G, Cs-Szabo G, Hoskin DW, et al: Lactoferricin
mediates anti-inflammatory and anti-catabolic effects via
inhibition of IL-1 and LPS activity in the intervertebral disc. J
Cell Physiol. 228:1884–1896. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Masuda K: Biological repair of the
degenerated intervertebral disc by the injection of growth factors.
Eur Spine J. 17 (Suppl 4):S441–S451. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang H, Cao C, Wu C, Yuan C, Gu Q, Shi Q
and Zou J: TGF-βl suppresses inflammation in cell therapy for
intervertebral disc degeneration. Sci Rep. 5(13254)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Boos N, Weissbach S, Rohrbach H, Weiler C,
Spratt KF and Nerlich AG: Classification of age-related changes in
lumbar intervertebral discs: 2002 Volvo Award in basic science.
Spine (Phila Pa 1976). 27:2631–2644. 2002.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Freemont AJ, Peacock TE, Goupille P,
Hoyland JA, O'Brien J and Jayson MI: Nerve ingrowth into diseased
intervertebral disc in chronic back pain. Lancet. 350:178–181.
1997.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Johnson WE, Caterson B, Eisenstein SM,
Hynds DL, Snow DM and Roberts S: Human intervertebral disc aggrecan
inhibits nerve growth in vitro. Arthritis Rheum. 46:2658–2664.
2002.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kwon WK, Moon HJ, Kwon TH, Park YK and Kim
JH: Influence of rabbit notochordal cells on symptomatic
intervertebral disc degeneration: Anti-angiogenic capacity on human
endothelial cell proliferation under hypoxia. Osteoarthritis
Cartilage. 25:1738–1746. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
He M, Pang J, Sun H, Zheng G, Lin Y and Ge
W: Overexpression of TIMP3 inhibits discogenic pain by suppressing
angiogenesis and the expression of substance P in nucleus pulposus.
Mol Med Rep. 21:1163–1171. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ge J, Zhou Q, Niu J, Wang Y, Yan Q, Wu C,
Qian J, Yang H and Zou J: Melatonin protects intervertebral disc
from degeneration by improving cell survival and function via
activation of the ERK1/2 signaling pathway. Oxid Med Cell Longev.
2019(5120275)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chang CC, Huang TY, Chen HY, Huang TC, Lin
LC, Chang YJ and Hsia SM: Protective effect of melatonin against
oxidative stress-induced apoptosis and enhanced autophagy in human
retinal pigment epithelium cells. Oxid Med Cell Longev.
2018(9015765)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen Y, Wu Y, Shi H, Wang J, Zheng Z, Chen
J, Chen X, Zhang Z, Xu D, Wang X and Xiao J: Melatonin ameliorates
intervertebral disc degeneration via the potential mechanisms of
mitophagy induction and apoptosis inhibition. J Cell Mol Med.
23:2136–2148. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cerezo AB, Hornedo-Ortega R,
Álvarez-Fernández MA, Troncoso AM and García-Parrilla MC:
Inhibition of VEGF-induced VEGFR-2 activation and HUVEC migration
by melatonin and other bioactive indolic compounds. Nutrients.
9(249)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Buser Z, Chung AS, Abedi A and Wang JC:
The future of disc surgery and regeneration. Int Orthop.
43:995–1002. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Freeman BJ and Davenport J: Total disc
replacement in the lumbar spine: A systematic review of the
literature. Eur Spine J. 15: (Suppl 3):S439–S447. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Van den Eerenbeemt KD, Ostelo RW, van
Royen BJ, Peul WC and van Tulder MW: Total disc replacement surgery
for symptomatic degenerative lumbar disc disease: A systematic
review of the literature. Eur Spine J. 19:1262–1280.
2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang W, Li P, Xu J, Wu X, Guo Z, Fan L,
Song R, Wang J, Wei L and Teng H: Resveratrol attenuates high
glucose-induced nucleus pulposus cell apoptosis and senescence
through activating the ROS-mediated PI3K/Akt pathway. Biosci Rep.
38(BSR20171454)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Murch SJ, Simmons CB and Saxena PK:
Melatonin in feverfew and other medicinal plants. Lancet.
350:1598–1599. 1997.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen G, Huo Y, Tan DX Liang Z, Zhang W and
Zhang Y: Melatonin in Chinese medicinal herbs. Life Sci. 73:19–26.
2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Reiter RJ, Tan DX and Galano A: Melatonin:
Exceeding expectations. Physiology (Bethesda). 29:325–333.
2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Reiter RJ, Tan DX and Korkmaz A: The
circadian melatonin rhythm and its modulation: Possible impact on
hypertension. J Hypertens (Suppl 27). S17–S20. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Alvarez-García V, González A,
Alonso-González C, Martínez-Campa C and Cos S: Antiangiogenic
effects of melatonin in endothelial cell cultures. Microvasc Res.
87:25–33. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cui P, Yu M, Peng X, Dong L and Yang Z:
Melatonin prevents human pancreatic carcinoma cell PANC-1-induced
human umbilical vein endothelial cell proliferation and migration
by inhibiting vascular endothelial growth factor expression. J
Pineal Res. 52:236–243. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Alvarez-García V, González A,
Alonso-González C, Martínez-Campa C and Cos S: Regulation of
vascular endothelial growth factor by melatonin in human breast
cancer cells. J Pineal Res. 54:373–380. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Binch AL, Cole AA, Breakwell LM, Michael
AL, Chiverton N, Cross AK and Le Maitre CL: Expression and
regulation of neurotrophic and angiogenic factors during human
intervertebral disc degeneration. Arthritis Res Ther.
16(416)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Holmes K, Roberts OL, Thomas AM and Cross
MJ: Vascular endothelial growth factor receptor-2: Structure,
function, intracellular signalling and therapeutic inhibition. Cell
Signal. 19:2003–2012. 2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ohba T, Haro H, Ando T, Wako M, Suenaga F,
Aso Y, Koyama K, Hamada Y and Nakao A: TNF-alpha-induced NF-kappaB
signaling reverses age-related declines in VEGF induction and
angiogenic activity in intervertebral disc tissues. J Orthop Res.
27:229–235. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cui P, Yu M, Lou Z, Dai M, Han J, Xiu R
and Yang Z: Intracellular signaling pathways involved in cell
growth inhibition of human umbilical vein endothelial cells by
melatonin. J Pineal Res. 44:107–114. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cui P, Luo Z, Zhang H, Su Y, Li A, Li H,
Zhang J, Yang Z and Xiu R: Effect and mechanism of melatonin's
action on the proliferation of human umbilical vein endothelial
cells. J Pineal Res. 41:358–362. 2006.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang J, Li Z, Chen F, Liu H, Wang H, Li
X, Liu X, Wang J and Zheng Z: TGF-β1 suppresses CCL3/4 expression
through the ERK signaling pathway and inhibits intervertebral disc
degeneration and inflammation-related pain in a rat model. Exp Mol
Med. 49(e379)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cai F, Zhu L, Wang F, Shi R, Xie XH, Hong
X, Wang XH and Wu XT: The paracrine effect of degenerated disc
cells on healthy human nucleus pulposus cells is mediated by MAPK
and NF-κB pathways and can be reduced by TGF-β1. DNA Cell Biol.
36:143–158. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu Y, Li Y, Huang ZN, Wang ZY, Nan LP,
Wang F, Zhou SF, Wang JC, Feng XM and Zhang L: The effect of
intervertebral disc degenerative change on biological
characteristics of nucleus pulposus mesenchymal stem cell: An in
vitro study in rats. Connect Tissue Res. 60:376–388.
2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Luo XW, Liu K, Chen Z, Zhao M, Han XW, Bai
YG and Feng G: Adenovirus-mediated GDF-5 promotes the extracellular
matrix expression in degenerative nucleus pulposus cells. J
Zhejiang Univ Sci B. 17:30–42. 2016.PubMed/NCBI View Article : Google Scholar
|
